Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Enhancement of Membrane B7-H3 Costimulatory Molecule but Reduction of Its Soluble Form in Multiple Sclerosis.
CD8-mediated inflammatory central nervous system disorders.
Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation-driven production of corticosterone.
The Brown Norway opticospinal model of demyelination: Does it mimic multiple sclerosis or neuromyelitis optica?
Minocycline effects on the CSF proteome of Experimental Autoimmune Encephalomyelitis rats.
The Ex Vivo Production of IL-6 and IL-21 by CD4(+) T Cells is Directly Associated with Neurological Disability in Neuromyelitis Optica Patients.
Do cortical lesions help us to distinguish MS from NMO?
Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial.
HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells.
Influence of yoga and aerobics exercise on fatigue, pain and psychosocial status in patients with multiple sclerosis: A Randomized Trial.
Central nervous system myeloid cells as drug targets: current status and translational challenges.
Methods and measures: what's new for MS?
Origins and significance of astrogliosis in the multiple sclerosis model, MOG peptide EAE.
The behavior-analytic origins of constraint-induced movement therapy: an example of behavioral neurorehabilitation.
Prognostic factors of acute partial transverse myelitis.
Hearing statement in multiple sclerosis: a case control study using auditory brainstem responses and otoacoustic emissions.
Nogo-A: Multiple Roles in CNS Development, Maintenance, and Disease.
Association of Viruses in Neurodegenerative and Neurobehavioral Diseases.
Kv1.3 Deletion Biases T Cells toward an Immunoregulatory Phenotype and Renders Mice Resistant to Autoimmune Encephalomyelitis.
Stress, Depression and Antidepressant Treatment Options in Patients Suffering from Multiple Sclerosis.
Accumulation of cortical hyperphosphorylated neurofilaments as a marker of neurodegeneration in multiple sclerosis.
Reproductive decision making after the diagnosis of multiple sclerosis (MS).
[Anti-NMDA receptor encephalitis - case report].
The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
The effect of intravenous immunoglobulin on neuromyelitis optica.
Pages
« first
‹ previous
…
233
234
235
236
237
238
239
240
241
…
next ›
last »